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Objective: lncRNAs are recently thought to play a significant role in cellular homeostasis
during pathological process of diseases by competing inhibiting miRNA function. The aim
of present study was to assess the function of long non-coding RNA (lncRNA) MEG3
and its functional interaction with microRNA-181b in cerebral ischemic infarct of mice
and hypoxia-induced neurons apoptosis.
Methods: To address this question, we performed the experiments with in vivo middle
cerebral artery occlusion (MCAO) mice model and in vitro oxygen-glucose deprivation
(OGD)-cultured neuronal HT22 cell line. Relative expression of MEG3, miR-181b, and
12/15-LOX (lipoxygenase) mRNA was determined using quantitative RT-PCR. Western
blot was used to evaluate 12/15-LOX protein expression. TUNEL assay was performed
to assess cell apoptosis.
Results: In both MCAO mice and OGD-cultured HT22 cell, ischemia, or hypoxia
treatment results in a time-dependent increase in MEG3 and 12/15-LOX expression
and decrease in miR-181b expression. Knockdown of MEG3 contributes to attenuation
of hypoxia-induced apoptosis of HT22 cell. Also, expression level of MEG3 negatively
correlated with miR-181b expression and positively correlated with 12/15-LOX
expression. In contrary to MEG3, miR-181b overexpression attenuated hypoxia-induced
HT22 cell apoptosis, as well as suppressed hypoxia-induced increase in 12/15-LOX
expression. By luciferase reporter assay, we concluded that miR-181b directly binds to
12/15-LOX 3′-UTR, thereby negatively regulates 12/15-LOX expression.
Conclusion: Our data suggested that long non-coding RNA MEG3 functions as a
competing endogenous RNA for miR-181b to regulate 12/15-LOX expression in middle
cerebral artery occlusion-induced ischemic infarct of brain nerve cells.
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INTRODUCTION
In recent years, with the increasing incidence of cerebrovascular
disease, the nerve injury caused by acute cerebral ischemia brings
an increasingly heavy burden on individuals and society. This
situation makes it a central issue to elucidate the molecular
mechanisms of acute cerebral ischemia-related neuronal injury
(Chen et al., 2014).
According to encode project, ∼80% of the human genome
is transcribed to RNA, of which ∼90% genome transcribes
into non-coding RNA. These non-coding RNAs are increasing
recognized and defined as endogenous regulatory RNA
involved in maintenance of cellular homeostasis during growth,
development and pathogenesis disease. Basing on different sizes,
these non-coding RNA are classified into miRNA (microRNA,
20∼22 nucleotides in length) and lncRNA (long non-coding
RNA, >200 nucleotides in length). Interestingly, lncRNA is
recently found to be a competing endogenous RNA for miRNA
and these interactions have been found in various pathological
mechanisms (Tay et al., 2014).
Studies have shown that ischemia alters cerebral miRNA
and lncRNAs that control epigenetic silencing or activation in
mammal (Dharap et al., 2009, 2013; Zhang et al., 2015), including
long non-coding RNAs (LncRNAs), also undergo changes in the
poststroke brain (Mehta et al., 2015). Although no direct evidence
focusing on the involvement of MEG3 in cerebral ischemic
injury, it was genetic phenotype silenced in brain disease and has
been recognized as a novel potentially tumor-suppressing RNA
in meningioma and glioma cell (Wang et al., 2012; Ouyang et al.,
2014). Moreover, several studies have suggested that miRNAs are
altered in response to ischemia reperfusion injury and regulate
the expression of various key elements in cell survival and
apoptosis. MiR-181b is a multifunction miRNA in brain. Fox
example, it can be function as a NMDA receptor dependent
plasticity-responsible miRNA in hippocampal neurons (van
Spronsen et al., 2013). Moreover, miR-181 is showed to be
involved in synaptic plasticity and memory processing of
Alzheimer’s disease mice via targeting functional gene expression
(Rodriguez-Ortiz et al., 2014). As for brain ischemia, miR-181
contributes to astrocyte, a neuroprotective cell for brain ischemia
(Ouyang et al., 2014), cell apoptosis in ischemic injury brain
and in vitro glucose deprivation cultured astrocyte (Ouyang
et al., 2012). Moreover, downregulation of miR-181b can protect
middle cerebral artery occlusion (MCAO)-induced ischemic
injury of mice brain (Peng et al., 2013). To be noted, study has
pointed out that MEG3 serves as a competing endogenous RNA
for miR-181 in other disease model. Therefore, our present study
was to evaluate the functional interaction between MEG3 and
miR-181b in cerebral ischemic infract and in hypoxia-induced
neuron apoptosis.
Recent studies showed that the neuronal 12/15-LOX was
robustly activated in the injured brain and mediated oxidative
stress-induced neuronal dysfunction contributing to neuronal
death after cerebral ischemia (Han et al., 2015; Jung et al., 2015).
We currently evaluated whether ischemia-responsive lncRNA
interact with miR-181b, associated with genetic phenotype
change of 12/415-LOX in cerebral ischemic mice.
MATERIALS AND METHODS
Animals Model of Middle Cerebral Artery
Occlusion
Middle cerebral artery occlusion (MCAO) model was established
in 6 month BALB/c mice. Briefly, animals were anesthetized with
sodium pentobarbital (30 mg/kg) via intraperitoneal injection
and were placed on heating panel inserting with rectal probe to
keep 37◦C temperature during operation. For the right MCAO
surgical procedure, a 1 cm incision was made for exposing the
right common carotid artery, external carotid artery, and internal
carotid artery. A 4/0 monofilament nylon suture with a rounded
tip obtained by heating was inserted into the right external
carotid artery and gently advanced into the internal carotid
artery until the rounded tip blocked the origin of the middle
cerebral artery. Sham-operated animals underwent the same
surgical operation without insertion of monofilament nylon.
At 6, 12, and 24 h after the onset of permanent occlusion,
animals (n = 6 per group) were sacrificed and, the brains were
immediately removed and coronally sectioned from −1.0 to
+3.0 mm bregma. These brain cortex tissues were collected and
stored in−80◦C refrigerator for subsequent analysis of RNA and
protein determination. This study was approved by the Ethical
Committee of Shandong University.
To evaluate role of MEG3 in cerebral ischemia injury, lipid
nanoparticles-formulated si- MEG3 or si-control (2.5 mg/kg
body weight) was intravenously injected into mice before MCAO
operation. One day post injection, MCAO mice model was
established. At 24 h after operation, motion function of mice was
assessed on the basis of moving distance within 3 min. Animals
were then sacrificed for evaluation of edema volume and infarct
volume.
Quantification of Infarct Volume and
Edema Volume
Animals were sacrificed and the brain was removed. The brain
cortex tissues were made into brain slices and used for analysis
of infarct volume and edema volume. Coronal sections of brain
(30µm; separated by ∼420 µm) were cut and then stained with
0.1% thionin. The infract area and edema area were analyzed and
calculated with ImageJ software. Infarct volume and brain edema
were determined by integrating the infarct area of different brain
slices areas with the use of cylinder and cone rules. To avoid
subjective factors, investigator who performs the analysis was
blinded to the treatment groups.
HT22 Cell Culture and Oxygen Glucose
Deprivation (OGD)
HT22 cells (a mouse hippocampal cell line) were obtained
from the American Type Culture Collection (ATCC). Cells
were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM)
containing 10% fetal bovine serum (FBS, Gibco) with 2 mM
glutamine, 100U/mL penicillin, and 100 µg/mL streptomycin
and maintained at 37◦C in a humidified incubator with 5% CO2.
Medium was replaced every 2 days. For in vitro OGD model,
HT22 cells were pre-exposed to an oxygen-depleted, glucose-free
medium for 15 min and then incubated in a hypoxic chamber
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(under condition of 5% CO2/95% N2) at 37
◦C. The hypoxic time
was set up at three intervals of 6, 12, and 24 h respectively.
Quantitative RT-PCR
Total RNA were extracted with TRIzol reagent, and miRNAs
were extracted by TRIzol SM Reagent (HaiGene, Haerbing,
China). After quantified by spectrophotometer, equal RNA
of each sample was reversely transcribed into cDNA using
PrimeScript R© miRNA or mRNA cDNA synthesis kit (TaKaRa,
Tokyo, Japan). The generated cDNA was amplified using
Platinum SYBR Green qPCR Super Mix UDC (Invitrogen,
Carlsbad, CA) in an ABI Prism 7000 (Applied Biosystems,
Foster City, CA). The genes encoding mouse MEG3, 12/15-
LOXmRNA, miR-181b were amplified with the following primer
pairs. Relative expression of these genes was calculated by the
2−11CT value method. Relative expression of MEG3 and 12/15-
LOX mRNA was normalized to GAPDH, and relative expression
of miR-181b was normalized to U6.
Primers for MEG3, 12/15-LOX mRNA, miR-181b are as
follows:
MEG3: 5′-CTGCCCATCTACACCTCACG-3′ (sense) and
5′-CTCTCCGCCGTCTGCG CTAGGGGCT-3′ (antisense)
12/15-LOX: 5′-ACCCCACCGCCGATTTT-3′ (sense) and
5′- AGCTTCGGACCCAGCATTT-3′ (antisense)
miR-181b: 5′-CAGACATCTCTGCCTCACA-3′(sense) and
5′-TTGCGGTTCTGTCTTCAGC-3′ (antisense)
Western Blot
Cells were lysed in RIPA buffer containing mixture proteinase
inhibitor. Proteins were extracted from lysate by centrifugation
at 10,000 × g for 10 min at 4◦C. Total protein concentration
was measured and normalized with the BCA protein assay kit
(Pierce Biotechnology, IL, USA). Twenty-five Microgram of total
protein was loaded in sodium dodecyl sulfate polyacrylamide
gel electrophoresis (SDS-PAGE) and were migrated by
electrophoresis. Proteins in gel were then transferred to
polyvinylidene fluoride membranes (Millipore). After blocked
by 5% non-fat milk in Tris-buffered saline containing 0.1%
Tween 20 (TBS-T) for 2 h at room temperature, membrane was
incubated with antibodies against 12/15-LOX and β-actin at
4◦C overnight. The following day, membrane was washed twice
with TBST and was incubated with goat anti-rabbit IgG-HRP
(1:4000) for 2 h at room temperature. Bands were detected
by chemiluminescence ECL kit in X-ray film developer and
quantified using ImageJ software.
TUNEL Assay
TUNEL assay is a method to detect fragmented DNA of apoptotic
cell and was used to evaluate cultured HT22 cells apoptosis with
Click-iT R© Plus TUNEL assay for in situ Apoptosis Detection
(Thermo Fisher Scientific) according to the manuals. Collected
cells were washed by PBS, and re-suspended at a concentration
of 107/ml in PBS. One hundred microliter of cell suspension
was then cultured in 48-well plate. After fixed by addition of
2% formaldehyde in PBS, cells were collected and postfixed with
70% ice-cold ethanol. The fixed cell were added with TUNEL
reaction buffer and incubated in TUNEL reaction mixture in
dark for 60 min at 37◦C. After reaction, samples were subjected
to fluorescence microscope (Olympus, Tokyo, Japan) and eight
visual fields of them were randomly selected to count the cells
with positive signals.
Transfection
For siRNA knockdown of MEG3, HT22 cells were transfected
with MEG3 siRNA (si-MEG3) or non-targeting control siRNA.
For miR-181b knockdown, HT22 cells were transfected with
MISSION R© Synthetic microRNA Inhibitor (Sigma-Aldrich) for
miR-181b with negative control (NC) as control.
For overexpressing MEG3, recombinant pcDNA plasmid
of MEG3 gene was transfected into HT22 cells with pcDNA
empty plasmid as control. For miR-181b overexpression, the
cells were transfected with miRIDIAN Mimics for miR-181b
(Dharmacon) as compared with pre-negative control (pre-NC).
All transfections were carried out using lipofectamine 2000
according to manufacturer guidelines and cells were harvested
after 48 h for subsequent experiments.
Dual Luciferase Reporter Assay for
12/15-LOX Promoter Activity
The promoter region of the 12/15-LOX gene was amplified
from mouse genomic DNA and was then introduced into the
KpnI and BglII sites of pGL3-Basic (Promega, Madison, WI) to
generate 12/15-LOX 3′-UTR-WT. Mutate 12/15-LOX gene was
also amplified and introduced into pGL3-Basic to generate 12/15-
LOX 3′-UTR-MU (served as control). The resulting plasmid was
designated as pGL3-12/15-LOX. HT22 cells were co-transfected
with miR-181b mimic or miR-181b inhibitor or negative control
and pGL3-12/15-LOX luciferase construct. Cells were harvested
at 24 h post-transfection for luciferase activity analysis using the
Dual-Luciferase Reporter Assay system (Promega,Madison,WI).
The amount of firefly luciferase activity was presented as the
increase or decrease (n-fold) relative to the value for the sample
lacking the miR-181b or overexpressing miR-181b.
Statistical Analysis
Data were presented as means ± sd (standard deviation).
Results were analyzed either by one-way ANOVA followed by
Dunnett’s multiple comparison tests or paired t test (version
5.00; GraphPad Prism Software Inc., San Diego, CA). Statistical
significance was considered for P < 0.05.
RESULTS
Gene Phenotype Changes of Infarction
Tissues in Middle Cerebral Artery
Occlusion Mice and in Neuronal HT22 Cell
during Glucose Deprivation
To examine aberrant genes expression in response to ischemia,
mice middle cerebral artery occlusion model was established
and infarction tissues were isolated for subsequent analysis
of quantitative RT-PCR and western blot. The data showed
that, at 6, 12, and 24 h post model establishment, relative
expression level of MEG3 is increased in a time-dependent
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manner (Figure 1A), whereas miR-181b is time-dependently
downregulated (Figure 1B). Specifically, ischemia time-
dependently caused upregulation of 12/15-LOX mRNA and
protein (Figure 1C).
To determine those abnormal genes expression in hypoxia-
injured neural cell, neuronal HT22 cell-Oxygen-glucose
deprivation (OGD) in vivo model of brain hypoxia was
established (Tasca et al., 2015). The data showed that OGD
FIGURE 1 | Time course of genes expression in infarction area of middle cerebral artery occlusion mice and in hypoxia-stimulated HT22 neural cell
line. After a series of 6, 12, and 24 h animal establishment, quantitative RT-PCR was performed to determine the relative expression of (A) MEG3, (B) miR-181b, and
(C) 12/15-LOX mRNA; (C) representative blots of 12/15-LOX protein expression by Western blot. HT22 cells were experienced 6, 12, and 24 h of glucose deprivation
for following gene expressional analysis. Relative expression of (D) MEG, (B) miR-181b, and (E) 12/15-LOX, and (F) 12/15-LOX protein expression were determined.
Data are presented as mean ± sd. *P < 0.05, **P < 0.01 compared with sham with no MCAO surgery or cell with no treatment.
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treatment causes the same gene expression trend of neuronal
cell as MCAO mice, in which showed upregulation of MEG3
(Figure 1D), downregulation of miR-181b (Figure 1E), and
upregulation of 12/15-LOX in a time-dependent manner
(Figure 1F).
Manipulation of MEG3 Affects
Hypoxia-Induced HT22 Cell Apoptosis
Considering the positive expression of MEG3 in neuronal cell
responding to hypoxia, we next manipulate cellular MEG3 by
RNA interference and examine the involvement of MEG3 in
hypoxia-induced neuronal cell apoptosis. As shown in Figure 2A,
si-MEG3 transfection significantly attenuates hypoxia-induced
cell apoptosis as compared with si-negative control treatment. In
particular, hypoxia-stimulated downregulation of miR-181b and
upregulation of 12/15-LOX was partly recovered (Figures 2B,C).
Recombinant that containing MEG3 gene was further
employed to ensure the important role of MEG3 in neuronal
cell apoptosis. Under the condition of the pcDNA-MEG3
transfection, cell apoptosis percentage is up to 7.2 times than
pcDNA control treatment (Figure 2D). Accordingly, MEG3
overexpression brings about inhibitory expression of miR-181b
(Figure 2E) and enhances expression of 12/15-LOX mRNA and
protein (Figure 2F).
Functional Interaction of MEG3 and
miR-181b Affects Hypoxia-Induced HT22
Cell Apoptosis
Considering the establishment that downregulation of miR-181b
of neuronal cell in response to hypoxia, the exploration to
determine whether miR-181b may also play a role in the progress
of hypoxia-induced neuronal cell apoptosis is particularly
important. We analyzed the cell apoptosis in miR-181b mimic
transfected cells in Figure 3A, where showed that miR-181b
overexpression significantly reduced cell apoptosis percentage as
compared with pre-negative control treatment. Specially, 12/15-
LOX is consequently downregulated bymiR-181b overexpression
under hypoxia condition (Figure 3B). On the contrary, RNA
interference of miR-181b by miR-181b inhibitor culture under
normal culture conditions effectively promotes expressions of
HT22 cell apoptosis (Figure 3C) and 12/15-LOX (Figure 3D).
As indicated in above data, both MEG3 and miR-181b
function as the key regulators for hypoxia-induced HT22 cell
apoptosis. We therefore evaluate the functional interaction
between MEG3 and miR-181b in HT22 cells by cell co-
transfection with pcDNA-MEG3 and miR-181b. We observed
that co-overexpression of MEG3 and miR-181b contributes to
inhibitory effect of MEG3 on 12/15-LOX expression (Figure 3E),
as well as abrogates pro-apoptosis action of MEG3 (Figure 3F).
miR-181b Regulates 12/15-LOX Expression
in HT22 Cell
Based on the above data suggesting a link between abnormal
miR-181b level and 12/15-LOX expression, we further test
whether miR-181b manipulation by siRNA knockdown or
recombination plasmid transfection may directly regulate 12/15-
LOX expression. By predicating in bioinformatics software, we
observed that complementary sequences of miR-181b in 12/15-
LOX 3′-UTR (Figure 4A). We next co-transfect 12/15-LOX
3′-UTR-WT with miR-181b mimic for purpose of evaluating
transcriptional activity of 12/15-LOX. Cell with 12/15-LOX 3′-
UTR-MU co-transfection was as positive control. Figure 4B
showed that fluorescence activity of 12/15-LOX is reduced by
miR-181b overexpression; accordingly, relative expression of
12/15-LOX is suppressed. We further investigated the effect
miR-181b inhibitor on 12/15-LOX transcriptional activity and
expression in Figure 4C, which showed knock down of miR-181b
contributes enhancement of fluorescence activity of 12/15-LOX,
as well as promotes 12/15-LOX expression (Figure 4C).
Knock Down of MEG3 Improves Infarct of
MACO Mice
Above data suggested that MEG3 is responsible for hypoxia-
induced neuronal cell apoptosis. We next determined the pivotal
role of MEG3 in cerebral infarction of MACO mice by animals
injected with si-MEG3. We observed the downregulation of
MEG3 in animals with si-MEG3 injection (Figure 5A). These
si-MEG3 injections significantly improved MACO-induced
brains infract volume and edema volume (Figure 5B) and also
promoted motion function of animals (Figure 5C). To confirm
the downstream miR-181b/12/15-LOX pathway of MEG3, we
next determined miR-181b and 12/15-LOX in infract position.
The data showed that miR-181b was upregulated and expression
of 12/15-LOXmRNA and protein was suppressed in animals with
si-MEG3 injection compared with si-NC (Figures 5D,E).
DISCUSSION
lncRNAs in the mammalian genome are characterized by
evolutionary conservation and tissue-specific expression pattern.
Moreover, accumulated studies have suggested that ectopic
expression and/or functionality of lncRNAs play a role in various
pathological processes including inflammation, oxidative stress
response, and ischemic injury. A major function attributed to
lncRNA is to competitively inhibit miRNA function by indirectly
liberating miRNA-restrained functional protein. Therefore, our
present study evaluated the interacting epigenetic change of
lncRNA MEG3 to miR-181b in focal cerebral ischemia injury of
mice subjected to middle cerebral artery occlusion (MCAO).
Our data described a global time dependent analysis of the
levels of hippocampal MEG3 and miR-181b during cerebral
ischemia and in OGD-cultured hippocampal HT22 cell line in
periods of 6, 12, and 24 h post hypoxia condition. We observed
that the MEG3 is gradually upregulated, whereas miR-181b
is gradually downregulated in both brain and HT22 cell with
increasing time of hypoxia. This data suggested the expressional
negative correlation between MEG3 and miR-181b in response
to brain hypoxia. Previously, the MEG3 and miR-181b works
have been confirmed to be involved in cerebral disease. For
example, MEG3 is recognized as a novel tumor suppressor for
brain tumor (Balik et al., 2013). MEG3 is also showed to be
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FIGURE 2 | Manipulation of MEG3 affects hypoxia-induced apoptosis in HT22 cell. HT22 cells were pre-transfected with si-MEG3 or si-NC for 24 h and then
deprived 12 h of glucose-free DMEM. (A) Cell apoptosis was evaluated by TUNEL assay. Expression level of (B) miR-181b and (C) 12/15-LOX mRNA and protein
were determined. Also cells were transfected with pcDNA-MEG3 or pcDNA empty plasmid for 24 h. (D) Cell apoptosis, expression level of (E) miR-181b and (F)
12/15-LOX mRNA and protein were evaluated. Data are presented as mean ± sd. **P < 0.01 compared to cell with no hypoxia treatment or pcDNA; ##P < 0.01
compared with hypoxia +si-NC.
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FIGURE 3 | Functional interaction of MEG3 and miR-181b mediates HT22 cell apoptosis. HT22 cells were pre-treated with miR-181b mimic or pre-NC before
exposed to glucose deprivation. (A) Cell apoptosis and (B) expression level of 12/15-LOX mRNA and protein were determined. (C) Cell apoptosis and (D) 12/15-LOX
expression were analyzed in miR-181b inhibitor treated HT22 cells. Cells were then co-treated with pcDNA-MEG3 and miR-181b mimic. (E) Expression level of
12/15-LOX and (F) cell apoptosis were determined. Data are presented as mean ± sd. **P < 0.01 compared to cell with no hypoxia treatment or NC or pcDNA;
##P < 0.01 compared with hypoxia +pre-NC or pcDNA-MEG3+pre-NC.
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FIGURE 4 | Manipulation of cellular miR-181b regulates12/15-LOX expression in HT22 cell. (A) Representative base-pairs between 12/15-LOX 3′-UTR-WT
and miR-181b with 12/15-LOX 3′-UTR-MU as positive control. (B) Cells were co-treated with 12/15-LOX 3′-UTR-WT or 12/15-LOX 3′-UTR-WT and miR-181b mimic;
fluorescence activity and 12/15-LOX expression were determined. (C) Fluorescence activity and 12/15-LOX expression were determined in 12/15-LOX 3′-UTR-WT or
12/15-LOX 3′-UTR-WT and miR-181b mimic co-transfected HT22 cells. Data are presented as mean ± sd. **P < 0.01 compared with 2/15-LOX 3′-UTR-WT or NC.
involved in production of gonadotropin-releasing hormone in
HT22 cell (Tao et al., 2015). In addition, accumulated studies
have demonstrated that miR-181b plays multifunctional roles
in brain disease. MiR-181 suppressed proliferation, migration,
and invasion of astrocytoma and was proved to be involved
in neuroinflammatory responses of astrocytes (Hutchison et al.,
2013; Zhi et al., 2014). Moreover, downregulation of miR-181b
can protect middle cerebral artery occlusion (MCAO)-induced
ischemic injury of mice brain (Peng et al., 2013). In present study,
we were the first to determine the functional interaction between
MEG3 and miR-181b in cerebral hypoxia injury.
Interestingly, MEG3 has been recognized as a competing
endogenous RNA for miR-181 in other experiments (Peng et al.,
2015). Basing on our data and online reference, we proposed
that MEG3 might function as a regulator for miR-181 in
ischemic neuron. Results that support this proposal are that
miR-181b is upregulated with the MEG3 knockdown under
hypoxia condition; and in normal condition, expression of miR-
181b is suppressed by MEG3 overexpression. Transient cerebral
ischemia during MCAO surgery may cause metabolic stress or
neurological disorders; while the visible appearance is death of
neuron (Sun et al., 2013; Zheng et al., 2015). To understand the
implication of altered lncRNA MEG3 and miR-181b in post-
stoke pathophysiology of neuron survival, we currently evaluate
whether this interaction promotes the functional association
betweenMEG3/miR-181b and the hypoxia-induced neuronal cell
apoptosis. The present data showed that knockdown of MEG3
or miR-181b overexpression can separately attenuate hypoxia-
caused HT22 cell apoptosis. This data suggested the critical
role of MEG3 and miR-181b in the development of ischemic
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FIGURE 5 | si-MEG3 injection improves cerebral infarction. Mice were injected with lipid nanoparticles-formulated si-control or si- MEG3 for 24 h before MCAO
establishment. (A) Relative expression of MEG3 in infract position was determined. (B) Infarct volume and edama volume and (C) motion function were evaluated.
Examination of (D) relative expression of miR-181b and (E) 12/15-LOX in infract site. Data are presented as mean ± sd. **P < 0.01 compared with siNC.
apoptosis of neuron. Moreover, the critical role of MEG3 in
cerebral ischemic injury was confirmed by decrease of infarct
volume and edema volume, and improved motion function
in siMEG3-injected MACO mice. Furthermore, the functional
interaction of MEG3 and miR-181b is reflected in experienced
pcDNA-MEG3 and miR-181b co-transfected HT22 cell. We
observed that miR-181b effectively reverses pro-apoptosis action
of MEG3 in HT22 cells and this data suggested the possible
neuroprotective action of miR-181b. This contradictory effect
of miR-181b with previous study (Peng et al., 2013) may be
by reason of experiments with different neural cell lines and
distinction of target gene for miR-181b.
These interactions were shown to be crucial for global
processes such as gene activation, as well as local events such
as the abnormal gene phenotype in response to hypoxia injury.
Interestingly, our data support this by showing that 12/15-
LOX is the responsive functional protein for MEG3/miR-181b.
Recent studies showed that 12/15-LOX upregulation promotes
neuronal death under post-hypoxia. Our data also support this
fact and showed the time course of 12/15-LOX upregulation in
infarction area of MCAO mice. 12/15-LOX is a key enzyme of
unsaturated fatty acid metabolism and plays a significant role in
the development of cerebral disease, such as Alzheimer’s disease
and Parkinson’s disease (Praticò et al., 2004; Chou et al., 2014). In
particular, the facilitating function of 12/15-LOX in pathological
process of cerebral ischemic injury has established in ischemic
HT22 neuronal cells and in transient focal ischemic brain of
rat (Jung et al., 2015; Sun et al., 2015). In addition, our data
showed that the physical abnormal 12/15-LOX expression is
positively affected by genetic silencing or activation of lncRNA
MEG3, whereas negatively regulated by aberrant expression of
miR-181b. 12/15-LOX also serves as a target gene for miR-
181b and its expression is inhibited via gene being integrated
by miR-181b as shown in Figure 4A. These data suggested that
12/15-LOX serves as a final responder for MEG3/miR-181b and
mediates hypoxia-induced apoptosis of neuron. We also found
that 12/15-LOX overexpression abrogated anti-apoptosis action
of miR-181b overexpression (data not shown).
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In summary, our present study is for the first time to
demonstrate that lncRNA MEG3 functions as a competing
endogenous RNA for miR-181b and this interaction plays
an important role in ischemia-caused neuronal cell apoptosis.
Meanwhile, during cerebral pathological injury, 12/15-LOX is the
responsive protein for this lncRNAMEG3/miR-181b axis.
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